Kumar, V. and Panda, B. K. (2017) “CAN COST OF PHARMACOLOGICAL THROMBOLYTIC THERAPY BE A MEDICATION MANAGEMENT STRATEGY FOR ACUTE CORONARY SYNDROME?”, Asian Journal of Pharmaceutical and Clinical Research, 10(3), pp. 363-366. doi: 10.22159/ajpcr.2017.v10i3.16308.